RussianPatents.com

Intraoperative combined spectroscopic diagnostic technique for cerebral and spinal tumours. RU patent 2497558.

Intraoperative combined spectroscopic diagnostic technique for cerebral and spinal tumours. RU patent 2497558.
IPC classes for russian patent Intraoperative combined spectroscopic diagnostic technique for cerebral and spinal tumours. RU patent 2497558. (RU 2497558):

A61P43/00 - Drugs for specific purposes, not provided for in groups ; A61P0001000000-A61P0041000000
A61N5/067 -
A61K31/197 -
Another patents in same IPC classes:
Fibrosis inhibitor Fibrosis inhibitor / 2497525
Invention refers to pharmaceutics and medicine and concerns a fibrosis inhibitor containing 2-{4-N-(5,6-diphenyl-pyrazin-2-yl)-N-isopropylamino]butyloxy}acetic aci or a pharmaceutically acceptable salt thereof or 2-{4-[N-(5,6-diphenyl-pyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulphonyl)acetamide or a pharmaceutically acceptable salt thereof as an active ingredient for treating interstitial pneumonia, pulmonary fibrosis, scleroderma or hepatic cirrhosis.
Method for maintaining physiological status in newborn calves / 2497519
Method refers to veterinary science and aims at maintaining the physiological status in newborn calves. The method involves using the biologically active substance coredon. Coredon is pre-mixed with ascorbic acid. This mixture is dissolved in water, fed to calves in the amount of 2 g, once a day, from the second after-birth day for 5 days.
Method for dermal flap survival growth in reduced circulation with minoxidil / 2497201
Dermal flap is simulated in laboratory animals on the second day of the experiment. On the first and fourth day of the experiment, minoxidil is introduced intraperitoneally in a daily dose of 1.0 mg/kg in two stages.
Agent for extreme performance stimulation, method for preparing and using it Agent for extreme performance stimulation, method for preparing and using it / 2496504
Group of inventions refers to medicine. The agent represents a mixture of peptides of molecular weight 500-900 Da prepared of the brain of cattle and/or pigs of one year old or younger, particularly the midbrain (mesencephalon), namely the central grey substance surrounding the Sylvian aqueduct (aquaeductus cerebri Sylvii) with the peptide mixture concentration in the agent of 5.0-10.0 mg/ml of the aqueous solution or the content of 5.0-10.0 mg/g in a witepsol suppository. The method involves grinding the cattle and/or porcine frozen midbrain, hydrolysis at +20°C in the presence of pepsin, extraction, separation of the extract from ballast substances by separation through materials with retention potential more than 2000 Da, separation of the purified extract by fluid extraction at critical temperature CO2 31.1°C and critical pressure 7.3±0.1 atm, separation of the fraction of 500-900 Da, dissolution in water and freeze drying. The agent is applied in the form of the solution in water in the active substance concentration of 5.0-10.0 mg/ml for single parenteral administration in a dose of 10-30 mg, or in the form of a witepsol suppository with the active substance concentration of 5.0-10.0 mg/ml for single rectal administration in a dose of 10-30 mg.
Methods and compositions for treating phenylketonuria / 2496489
Declared invention refers to medicine and aims at treating phenylketonuria. What is declared is a dosage form containing a) phenylalanine-4-hydroxylase and/or phenylalanine ammonia-lyase and b) at least one peptidase, wherein a), b) or both a) and b) have an enteric coating.
Method for increasing radioactive irradiation sensitivity in animals / 2495665
Invention relates to veterinary science and may be used to increase the radioactive irradiation sensitivity in animal tissues. That is ensured by the pre-radiation parenteral administration of gamma-aminobutyric acid lithium salt in a dose of 40 to 120 mg per 1 kg of body weight.
Sip receptor modulators for treating multiple sclerosis Sip receptor modulators for treating multiple sclerosis / 2495664
Present group of inventions refers to medicine, namely neurology, and concerns treating multiple sclerosis. That is ensured by the oral introduction of the S1P receptor modulator representing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol or a pharmaceutically acceptable salt thereof in a daily dose of 0.5 mg.
Gm-csf receptor binder Gm-csf receptor binder / 2495050
Present invention refers to biochemistry and immunology. What is considered is an isolated antibody molecule which binds an alpha chain of human granulocyte/macrophage colony stimulating factor receptor (GM-CSFRα) and inhibits GM-CSF binding to human GM-CSFRα. There are presented: a composition for GM-CSFRα inhibition or neutralisation and a composition for treating rheumatoid arthritis, asthma, chronic obstructive pulmonary disease or myeloid leukaemia, containing the antibody under the invention; the isolated nucleic acid molecule coding the antibody under the invention, a host cell and a method for preparing the antibody under the invention, as well a method for inhibiting or neutralising GM-CSFRα activity and a method of treating rheumatoid arthritis, asthma, chronic obstructive pulmonary disease or myeloid leukaemia in a patient.
Method for prevention of purulent complications in pancreatonecrosis / 2494743
Invention refers to medicine, and aims at prevention of the purulent complications of pancreatonecrosis. Patient's intestinal mucosal permeability is evaluated by the mannitol/lactulose test. If the urine mannitol/lactulose relation falls within the range of 0.03 to 0.05, a nasojejunal catheter is used to introduce 0.25% Derinat 10ml dissolved in physiological saline 50 ml into the intestine. If the urine mannitol/lactulose relation exceeds 0.05, 0.25% Derinat 20ml dissolved in physiological saline 50 ml is introduced into the intestine using the nasojejunal catheter. The preparation is introduced once a day for 3-4 days.
Method for preventing and treating fungal infection in patients with voice prostheses / 2494726
Invention refers to medicine, namely to otorhinolaryngological oncology, and may be used for preventing and treating fungal infections in the patients with voice prostheses. That is ensured by using the fresh aqueous solution 'Hydrolactiva'. This solution is used for oral treatment from the first day after laryngectomy and voice prosthesis positioning. After a probe is removed, a posterior prosthesis inside the oesophagus and pharyngoesophageal walls are treated. The aqueous solution 'Hydrolactiva' is prepared in the ratio - 20-25 g of a dry substance per 150 ml of warm water. The oral cavity is treated by rinsing with the solution 'Hydrolactiva' 3-5 times a day. After the probe is removed, this solution is used for the further treatment of the prosthesis cavity and protection valve. The posterior prosthesis and pharyngoesophageal walls are treated with 150 ml of the solution 'Hydrolactiva' orally administered through a straw with a patient's head and body inclined forward.
Method of treating gonarthrosis Method of treating gonarthrosis / 2497557
Invention relates to medicine, rheumatology and physiotherapy and may be used for treating gonarthrosis. A patient's rehabilitation index is calculated. Sonography is conducted, and the foot effusion volume is measured. A joint pain intensity is shown by a visual analogue scale. A body weight index is calculated, and the presence of diabetes mellitus and metabolic syndrome is stated. A radiation area is delimited and squared. The area is exposed to laser light at wave length 0.89 mcm. A pulse repetition frequency is specified in compliance with the effusion volume and joint pain intensity. An exposure dose per a session is determined with regard to the body weight index, the carbohydrate and lipid metabolic status, the patient's rehabilitation potential. At two frequencies, the exposure dose for each frequency makes ½ of the exposure dose per a session.
Method of treating benign neoplasms of larynx / 2497471
Invention relates to field of medicine, namely to otolaryngology, and can be applied in treatment of benign neoplasms of larynx. method consists in surgical treatment with application of photodynamic therapy (PDT), which includes introduction of photosensitiser into patient's organism with further laser irradiation of neoplasm zone. Intubation of patient with endotracheal tube with inflatable cuff on end is carried out. Detachable reflector, facing the side of lower surface of vocal folds, is installed into endotracheal tube in lower part of larynx between vocal folds and inflatable cuff at 50-80° towards trachea side. Additional irradiation of lower part of larynx, including lower surface of vocal folds, is carried out simultaneously by reflected laser irradiation by means of reflector. Duration of photodynamic therapy session constitutes on average 600 s, with irradiation power being 1.5 W.
Method of treating intracranial small-volume haematomas / 2496536
Invention concerns medicine, namely neural diseases, neurosurgery, traumatology. A neck surface is exposed to autoresonant red emission in a projection of carotid sinus at wave length 0.63-0.66 mcm, power 24-26 mWt for 7-10 minutes and to infrared emission at wave length 0.87-0.89 mcm, power 9-10 Wt for 10-15 minutes. That is followed by pharmacological neuroprotection by intranasal electrophoresis with neuroprotective preparation at current intensity 0.5-2.0 mA for 15-20 minutes. The treatment is started from the third post traumatic day. The first therapeutic day required the exposure to red laser light followed by a 15-20-minute pause and the intranasal electrophoresis in the morning with the exposure to red laser light in the evening. On the second therapeutic day, the exposure to red laser light is performed in the morning, and in the evening the same is followed by a 15-20-minute pause and the intranasal electrophoresis. The treatment is conducted within 14-20 days.
Method of treating spinal ischemia in experiment / 2496513
Invention refers to experimental medicine and may be used to treat simulated spinal ischemia in a biological object. The method involves three intraperitoneal administrations of human recombinant erythropoietin in 4-6, 24 and 48 hours after the action caused spinal ischemia. The amount of human recombinant erythropoietin per an injection is 5000 IU/kg. In 30-60 minutes after the first dose of human recombinant erythropoietin has been administered, a region in a projection of a spinal ischemia centre increased by 1-2 cm from the end above the affected region is exposed to diffuse percutaneous irradiation. The patient is exposed to infrared light generated by a diode laser at wave length 890 nm, power 2 Wt. The exposure is performed in the continuous mode for 3 minutes at 3-4 cm from the body surface of the biological object within the exposure area with the light guide movable at 5 mm/sec. The light guide moves along the exposure area spirally.
Method of acquired myopia treatment in conditions of stereoscopic vision / 2496455
Invention relates to medicine, prevention and treatment of acquired myopia. Method includes simultaneous carrying out optical-reflex and stereoscopic exercises. For this purpose created are conditions for passage of short-wave part of spectrum of day light, which consists of violet, blue, azure, green colours with wave length in range from 380 to 575 nm, for one eye, and for the other - long-wave part of spectrum of day light, which consists of yellow, orange, red colours with wavelength in range from 575 to 760 nm, with simultaneous carrying out session of optical-reflex exercises by patient. Creation of such conditions is possible due to alternation of colour light filters, placed into slots of lens-holders on apparatus "Vizotronik", before each following session of treatment.
Method of surgical treatment of disseminated destructive pulmonary tuberculosis / 2496430
Invention relates to field of medicine, namely to thoracic surgery and can be used in carrying out lung resection caused by dissiminated tuberculosis, main forms of which are fibrous-cavernous tuberculosis and caseous pneumonia. Method consists in carrying out thoracotomy, isolation of lung from fusions and carrying out revision of lung parenchyma by isolation of lung tissue with main tuberculosis process and lung tissue with tuberculosis foci of dissemination, ablation of lung tissue with main tuberculosis process, performing hemostasis, drainage of pleural cavity and suturing thoracotomic wound. Puncture of parenchyma is performed in lung tissue with tuberculosis foci of dissemination. After that, light guide is introduced through it to supply irradiation directly into focus of tuberculosis changes. Impact with high-energy laser with irradiation wavelength 970 nm is performed with power of irradiation flow 10-15 W and temporary exposure 0.2-0.5 sec. Application of claimed invention makes it possible to perform destruction of tuberculosis foci in lung tissue with preservation of parenchyma which surrounds them, ensure smaller over-stretching of lung parenchyma in postoperative period and thus preserve vital capacity of lungs, to minimise risk of intra-operation complications, including damage to elements of lung root in the process of processing. Parameters of laser irradiation and exposure time ensure destruction of tuberculosis foci of lung tissue, which remain in parenchyma after cavern ablation.
Method for integrated treatment of acute epididymo-orchitis caused by gram-positive and gram-negative microflora / 2495692
Invention refers to medicine, namely urology, and may be used for treating acute epididymo-orchitis. With underlying antibacterial therapy, a photodynamic therapy (PDT) is applied by intravenous administration of the photosentitiser "Photolon" 1-1.5 mg/kg. The patient is irradiated intravenously for 10 minutes, and then locally - for 5 minutes. Wave length of the laser radiation is 662±3 nm; radiation power is 1-2.1 Wt in an exposition dose of 60 J/cm2.
Method for prevention of hyperesthesia following ododentical tooth preparation for permanent dental prostheses with preserved pulp vitality / 2495691
Invention relates to medicine, namely dental orthopaedics, and may be used for the prevention of hyperesthesia accompanying dental prosthetics using permanent dental prostheses with preserved pulp vitality. After ododentical abutment preparation has been completed, the abutment stump prepared for prosthetics is exposed to LED laser at a distance of 2-2.5 mm from the tooth stump surface, with a light guide having a thickness of 320 mcm moving circularly at rate 2-4 mm/s, wavelength 970 nm +/- 15 nm, power 1-1.5 Wt and frequency 75-100 Hz for 10-20 seconds.
Method for prosthodontic treatment with permanent dental prostheses with preserved pulp vitality / 2495690
Invention relates to medicine, namely dental orthopaedics, and may be used for prosthodontic treatment using permanent dental prostheses with preserved pulp vitality. After ododentical abutment preparation has been completed, the abutment stump prepared for prosthetics is exposed to LED laser at a distance of 2-2.5 mm from the tooth stump surface, with a light guide having a thickness of 320 mcm moving circularly at rate 2-4 mm/s, wavelength 970 nm +/- 15 nm, power 1-1.5 Wt and frequency 75-100 Hz for 10-20 seconds. That is followed by casting to make a prosthesis to be fixed onto the abutments.
Method of treating subacute and chronic non-specific cervicitis in nulliparae, involving course of laser photophoresis using balneological product elton gel / 2495689
Invention refers to medicine, gynaecology and concerns treating non-specific cervicitis in nulliparae. What is involved is an etiotropic therapy according to the microscopic and bacterioscopic findings in a combination with a 10-day course of laser photophoresis started in the first phase of menstrual cycle for two menstrual cycles. For this purpose, the involvement area is coated with the balneological product 'Elton-gel' with the uterine cervix to be thereafter exposed to laser light at wavelength 0.9 nm, pulse power 5 Wt, pulse repetition frequency 600 Hz. The length of exposure for each locus makes: 2 minutes in first cervicitis, 3 minutes in the process of more than 1 year or the disease suffered for more than one year and the presence of more than two episodes of recurrence.
Tapentadol compositions for pain management Tapentadol compositions for pain management / 2497512
Given invention refers to a sustained-release tapentadol composition also containing a second active agent, wherein the above second active agent is specified in tramadol, pregabalin, gabapentyl, or pharmaceutically acceptable salts thereof. The given composition may be used to prepare a therapeutic agent for pain management. Besides, the present invention refers to a method of managing pain and conditions related to pain, by administering the given composition. The given invention also refers to a kit including a sustained-release tapentadol formulation also containing the second active agent, wherein the above second active agent is specified in tramadol, pregabalin, gabapentyl or pharmaceutically acceptable salts thereof.

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to neurooncology, and may be used for the intraoperative diagnosis of cerebral and spinal tumour borders and determination of the tumour resection quality. What is presented is an intraoperative combined spectroscopic diagnostic technique for cerebral and spinal tumours which involve the preoperative preparation including the oral administration of hydrochloride-5-aminolevulinic acid (several hours before the tumour resection). Actually the intraoperative spectroscopic analysis of the tumour marker content in the analysed tissues (5-aminolevelinic acid-induced protoporphyrin IX), as well as its desintegration products, oxygenated and reduced hemoglobin; the tissue scattering properties are varied using broadband and laser geode light source and a fibre-optic probe. The broadband light source is used within the range of 500÷600 nm, while the exiting fluorescent laser/diode light source - at wave length 620÷640 nm. The diffuse-reflectance spectra of the broadband and laser/diode light, as well as fluorescence are recorded at the same time. After the spectroscopic characteristics have been automatically classified, the operative radicality is assessed.

EFFECT: presented method enables higher reliability of the intraoperative measurements in neuronavigation, reducing time needed for implementing them, providing deeper probing and simplifying the spectra recording in vivo.

4 cl, 9 dwg, 3 ex

 

The present invention relates to medicine, namely to the neuro-Oncology, and may be used for intraoperative diagnostic boundaries brain and spinal cord tumors and determine the quality of tumor resection.

Currently there is a significant increase in the frequency of oncological diseases of the Central nervous system. Of particular difficulty is the definition of the boundaries of the cerebral and tumors. Urgency of the problem of determining the boundaries of astrocytic tumors caused by features of their growth along nerve fibers and blood vessels, leading to infiltration healthy white matter of neoplastic cells, which affects the high frequency of postoperative recurrence. The complexity of the surgery tumors of the spinal cord is that the tumor is not always a clear line and a high risk of trauma due to the smaller size of the operated plot compared with the brain. Reliable information about the amount tumor can be obtained by intraoperative imaging. The solution to this problem is mainly realized in three directions: use of intraoperative computer tomography, magnetic resonance imaging and ultrasound scanning, and different combinations of these methods [bitraoperative Imaging in Neurosurgery: MRI, CT, U/S, Springer-Verlag, Vienna, 2003; Radiology Research and Practice, Volume 2012 (2012), Article ID 197364, 9 pages; Acta Neurochirurgica (Wien), 2007; 149(4):365-78].

Unfortunately, all these ways of intraoperative diagnosis do not allow for the study of tissues in the operating wound in real time and/or do not provide simultaneous analysis of structural and metabolic changes.

Meanwhile, clinical studies have demonstrated a significant correlation between the level of accumulation of 5-aminolevulinic acid (5-ALA) - induced protoporphyrin DC and the speed of cell division that allows the use of this substance as a tumor marker. However, due to the fact that in 20-30% of cases, there was only a slight accumulation of drug in the tumor cells, additional criteria for intraoperative diagnosis of the investigated tissues. As is known, the tumor tissue and healthy brain tissue characterized by differences in the structure of tissues and the degree of and hemoglobin oxygenation. Thus, the simultaneous determination of these parameters allows to increase sensitivity of the method, based on the determination of the concentration of tumour marker (5 ALA-induced protoporphyrin IX).

Therefore very important problem is the development of a way to quickly intraoperative analysis of the tissues on the totality of the characteristic features during removal of tumors of the brain and spinal cord. Fluorescence spectroscopy and diffuse reflectance spectroscopy to provide you with accurate, fast and non-invasive methods of metabolic and structural changes in the tissues.

The closest analog to the present invention (prototype) is a method of combined spectroscopy, described in the article [Journal of Biomedical Optics 16 (11), 116007-14 (November 2011]. In this article, we propose a method of combined spectroscopy, combining analysis of spectra diffuse scattering of radiation of a pulsed broadband source in the range from 450 up to 720 nm obtained for the two distances between the lighting and the adoptive fibers, and the fluorescence spectrum of 5-ALA induced protoporphyrin IX and products of its photodecomposition range from 600 to 720 nm caused by radiation with the wavelength of 405 nm. Few hours before the operation the patient's organism is introduced solution hydrochloride 5-ALA. Then during operation resection of tumors produce consistent measure the spectrum of the background radiation of two spectra: diffuse scattering and fluorescence spectrum. The total time required for registration of all spectral dependencies in each point is about three seconds. To obtain the spectral characteristics of the use fiber optic sensor with three lighting fiber and two receptions. Received spectroscopic data treated with diffusion approximation theory of radiation propagation in a turbid medium, the optical characteristics which correspond to the optical characteristics of the tissue studied. The resulting data allow us to quantify the following parameters: the concentration of 5-ALA-induced protoporphyrin IX and products of its photodecomposition, concentration of hemoglobin in the oxygenated and reduced form of the scattering properties of the fabrics. For the implementation of the diagnostic algorithm is used by the support vector machine, which is a method of classification with a «teacher», in the space of five characteristics obtained in the result of mathematical treatment of the spectral dependencies. According to the results of the automatic analysis make a conclusion about radical held resection.

Disadvantages of using this method is consistent record spectra of background light, diffuse scattering and fluorescence, which requires measurement of all parameters required for the classification of tissue, about 3 C, and not allow measurements in real-time and reliably establish that the spectra were obtained from the same point in the same conditions. Another drawback of the method selected by us as a prototype, is the use of fluorescence shortwave radiation (wavelength 405 nm), for which the biological tissue is an environment with low transparency, which leads to reviewing the basics of fluorescence sensing tissue amount not to exceed several microns, and requires pre flush tissue of blood prior to optical measurements. These shortcomings complicate the procedure of tissue analysis by the method of optical biopsy.

Objective of the proposed invention is a method to enhance the reliability of measurements, reduce the time of their implementation, increase the depth of sounding and simplifying the process of registration of spectra in vivo.

The problem is solved by way of intraoperative holding spectroscopic diagnostics of tumors of the brain and spinal cord, including preoperative introduction to the patient hydrochloride solution of 5-ALA and intraoperative spectroscopic analysis of the content of the investigated tissues tumour marker (5-ALA induced protoporphyrin IX), products photodecomposition, and reduced hemoglobin, and changes in the scattering properties with the use of sources of broadband and laser and fiber-optical probe, with subsequent automatic classification spectroscopic characteristics of serving to assess efficacy of conduct resection. The proposed method is carried out using the source of broadband radiation in the wavelength range from 500 to 600 nm nm and the source of the laser/led radiation with a wavelength in the 620-640 nm, registration of spectra of the diffuse reflection and fluorescence produce simultaneously, then the accumulation level tumour marker of 5-ALA induced protoporphyrin DC determined by the degree of affiliation of the measured sample of tissue to the previously defined classes, the results of which assess the radical resection of a tumor.

The task is solved by the fact that for the automatic processing of spectroscopic characteristics using data classification method. The nearest neighbors in the space of the characteristics listed above.

The task is solved by the fact that according to the results of automatic classification form a sound signal, modulated by the loudness and frequency depending on the degree of malignancy of the tissue studied.

The task can be solved by the fact that according to the results of automatic classification form the maps of distribution of biomarkers.

The proposed method is using cross system of lighting and imaging filters, which implements the splitting of the spectral range on the area of registration the spectrum of the diffuse reflection of broadband radiation source (in the range from 500 to 600 nm nm), the intensity of scattering of laser radiation in the range 620-640 nm, which corresponds to the area of long-wave peak Q-absorption bands of protoporphyrin DC, in which biological tissue is optically transparent) and fluorescence spectrum (in the range 640-850 nm). Device for intraoperative combination of spectroscopic diagnostics of tumors of the brain and spinal cord matches the variant of the device described in the patent of Russian Federation №2169590 (IPC A61N 5/06, 2000).

The technical result, at the expense of the totality of features is to provide fast and reliable obtaining spectroscopic characteristics of one and the same volume of tissue in the area of operations for all of the above characteristics and simplification of process due to eliminating the need to pre flush tissue of blood prior to diagnosis.

In accordance with the invention, in the framework of preoperative preparation is performed oral administration to the patient hydrochloride solution of 5-aminolevulinic acid for a few hours before the beginning of the removal of the tumor.

Classification of recorded thus spectroscopic characteristics may be performed via the automatic mapping of spectroscopic and/or physiological characteristics of a database of relevant spectroscopic and/or physiological characteristics of fabrics, the condition of which was verified by histological analysis, methods of automatic classification, the results of which formed the conclusion about the degree of relationship of the tissue studied to one group or another in the framework of the adopted classification of tissues.

To inform the surgeon about the state of fabric on the results of the automatic classification of spectroscopic data may be used as visual and sound indication. For emphasis, the surgeon on the change of the spectral characteristics in the process of operation based on the results of their automated processing possible to use sound indication modulated by the loudness and frequency depending on the degree of malignancy tissues. Also, the formation on the screen two-dimensional maps of distribution of spectroscopic and/or physiological characteristics of fabrics to visualize the presentation of joint distribution of the studied biomarkers.

The invention is illustrated by the following figures.

Figure 1 provides for A patient under paragraph (a - preoperative MRI; b - photography cortex over the tumor in the white light; in - picture distribution of fluorescence cortex over the tumor mode Blue 400 intraoperative microscope Opmi Pentera.

Figure 2 shows for patient A view of the surgical bed in the mode of Blue 400 (time 18.16.07) before the spectroscopic data, (b) at the time of the combined spectroscopy (time 18.16.19-18.16.21), as well as in the mode of Blue 400 (in) after a short aspiration in the position of holding combined spectroscopic analysis. Presents the spectra 208-209 (g)registered in the moment shown in fig.2, as well as the corresponding values of oxygenation, the intensity of light scattering and index fluorescence, rated maximum values obtained in this study (e). Intraoperative were obtained the following values of these parameters are: range 208 - oxygenation 53%, the amplitude of backscattered laser radiation 800, index fluorescence 8.7; range 209 - oxygenation 26%, the amplitude of backscattered laser radiation 210 index fluorescence 7.5.

Figure 3 presents the maps of joint distribution of the studied spectroscopic values for normal, tumor tissue, as well as in the operational couch after removal of the tumor, the patient A. The following notation is used points in three-dimensional space, belonging to different classes: ▲ - the edge of the tumor ( area),, I - tumor, x - box after removal of the tumor, ✖ - intact neural tissue. All values are normalized to the maximum values obtained in result of the study. a - x-axis intensity of backscattered laser radiation, on the axis of ordinates index fluorescence; b - the x-axis is the degree of saturation of hemoglobin oxygen, on the axis of ordinates index fluorescence; the abscissa axis postponed the value of degree of saturation of hemoglobin oxygen, op axis shows the intensity of backscattered laser radiation.

Figure 4 shows the results of morphological study tissue samples taken during the surgery the patient And, allowed to make the final conclusion - : a - tumor, b - tumor.

Figure 5 present intraoperative image capture operation remove the tumor patient B in the white light of (a) and in the mode of Blue 400 Carl Zeiss Opmi Pentero (b)showing the presence of blood in the operational bed and weak heterogeneous fluorescence (the time 11.04.40-45), not allowing to make an unambiguous conclusion about the degree of accumulation of tumour marker in the tissue.

Figure 6 shows the results of the combined spectroscopic analysis of tissue B in the area of a box, shown in figure 4: range №36 (a), as well as the corresponding index values fluorescence (b) and oxygenation (). Index fluorescence 26, the amplitude of backscattered laser radiation 350, oxygenation 56%.

Figure 7 shows the results of morphological study of a patient's tumor B., with the final conclusion - anaplastic : a - zone infiltration of the tumor; b - zone infiltration of the tumor; the tumor; Mr. swelling and infiltration area.

On Fig.8 shows the intraoperative spectra obtained by the method of combined spectroscopic analysis of patient Century Range, marked with green, corresponds to a normal brain, the range indicated by the , obtained from tumor tissue, range, marked in orange, registered from the edge of the tumor.

Figure 9 shows the results of morphological study of the tumor, the patient - drugs detected ependymoma.

The following examples illustrate the proposed invention.

Example 1.

The patient, a 23-year (final diagnosis - the left frontal lobe (Grade II classification of the world health organization) operated 17.04.2012 (first time). 2 hours before surgery, the patient orally introduced a solution hydrochloride 5-aminolevulinic acid () in the amount of 20 mg/kg of patient's weight. After conducting trephination and dissection of Dura rendered bark of the left frontal region on the surface of the tumor site, bright fluorescent highlighting mode BL 400 on the operating microscope Carl Zeiss Opmi Pentero with fluorescent module (see intraoperative pictures figure 1). In figure 1. presents preoperative MRI (a) in patients with intracerebral tumor is visualized big tumor left frontal lobe (Grade II); intraoperative photo in white light (b) and in the mode of Blue 400 Carl Zeiss Opmi Pentero (), demonstrate a bright visible fluorescence of the first phase of operation. Started removal of the tumor. In the process of operation periodically assessed visual fluorescence of the wound and control markers of the state examined tissues by using the proposed method of a combined spectroscopy.

To use this source of broadband radiation in the range of 500 to 600 nm for analysis the concentration of hemoglobin in the oxygenated and reduced form and source of laser radiation with a wavelength in the 632.8 nm for the analysis of parameters of the light scattering and fluorescence excitation of 5-ALA induced protoporphyrin IX and products of its photodecomposition. When casting a fiber-optic probe in soft contact with the cloth produced simultaneous registration of spectra of the diffuse reflectance and fluorescence.

The places of intensive accumulation of 5-ALA removed completely, was a gradual decline in the intensity visible fluorescence in the course of the operation as the deepening of the wound. During the operation, the tumor visually almost no different from the medulla. At this stage the most sensitive tool for assessing the condition of the tissue in the operating wound was the method of combined spectroscopy. A series of intra-frames and spectral dependences submitted in figure 2, shows spectroscopic detection of fluorescent focus (2, b)not submitting visualization using mode Opmi Pentera Blue 400 (figure 2, a). In the study of combined spectroscopy revealed a range of 208 index fluorescence 8.7, the amplitude of backscattered laser radiation 800, oxygenation, 53%; range 209 index fluorescence 7.5, the amplitude of backscattered laser radiation 210, oxygenation, 26% (figure 2 g, d).

When conducting combined spectroscopic analysis in real time produced a classification of the tissue studied based on the automatic analysis of spectroscopic characteristics of the method To the nearest neighbours. As a method of display used two-dimensional maps of the distribution of values of the studied physiological markers (figure 3).

In the course of the operation was conducted fence material for morphological analysis of tissue samples in comparison with data of spectral analysis (figure 4). Differences in the level of scattering shown on fig.2 corresponding equally effective accumulation of protoporphyrin IX (fig.2) can be attributed to morphological difference plots tumour containing as Astro-and (fig.4, b). After obtaining parameters of combined spectroscopy from the bed walls of the removed tumor, identical to the normal brain, the main stage of the operation ended.

Example 2.

In the combination spectroscopy maximum index fluorescence was 26 Rel. units, the amplitude of backscattered laser radiation at the same point amounted to one third of the value of this parameter in normal tissue oxygenation at the same point was 56% (6). Of the points of realization of combined spectroscopic analysis were taken examined tissue biopsies (fig.6, b, C, d). The results of intraoperative mapping of spectral dependencies and morphological data reports served to enrich the database of spectroscopic/physiological to increase the accuracy of determining the membership of the investigated tissues to certain classes.

After obtaining parameters of combined spectroscopy, from the fabric of the bed of the removed tumor, identical to the normal brain, the main stage of the operation ended.

Example 3.

The patient, a 31-year (final diagnosis - tumor (ependymoma) at the level of Th2-Th3 vertebrae) was operated for the first time 03.04.2012, 2 hours before surgery, the patient orally introduced a solution hydrochloride 5-aminolevulinic acid () in the amount of 20 mg/kg of patient's weight. After approaching a tumor assessed visible fluorescence with the help of an endoscope with a fluorescent module - there were lots of bright homogeneous-type visible fluorescence. Resection of residual tumor, because the sensitivity of endoscopic module is insufficient, was combined spectroscopic analysis in the operational bed. For combined modality spectroscopy were used two sources of radiation - halogen lamp with a filter that removes the radiation in the range of 500 to 600 nm and helium-neon laser (632.8 nm). When casting a fiber-optic probe in soft contact with the cloth was made simultaneous registration of spectra of the diffuse reflectance and fluorescence. Real-time occurred classification of the tissue studied based on the automatic analysis of spectroscopic characteristics. According to the results of classification formed a sound signal, modulated by the loudness and frequency depending on the degree of malignancy examined tissue, on screen display the recorded spectra. In Fig.8 (b) shows the three spectra obtained intraoperative during the removal of the tumor, the patient Century Range, marked with orange, registered from the tumor margins, as evidenced intermediate between normal and tumor index value of fluorescence intensity of backscattered laser radiation. Easy normal tissue may be due to traction spinal cord tissue during surgery. The results of the spectroscopic analysis were confirmed morphological study tissue samples taken from the same points that hosted the spectral analysis (fig.9, b). The main stage of the operation was completed after the receipt of the spectral characteristics of the tumor bed, corresponding to normal tissue.

The proposed method is based on the actual material received by us at the analysis of 99 patients with gliomas of the brain Grade I-IV (WHO), 16 patients with metastatic tumors to the brain and 21 patients with meningiomas of the various levels of brain malignancy.

Thus, the proposed method solves the problem of increasing the reliability of intraoperative measurements at , reduce the time of their implementation, increase the depth of sounding and simplify the process of registration of spectra in vivo.

1. Method of combined intraoperative spectroscopic diagnostics of tumors of the brain and spinal cord, including preoperative introduction to the patient orally hydrochloride solution of 5-aminolevulinic acid (5-ALA) and the intraoperative spectroscopic analysis of the content in the studied tumor tissues marker (5-ALA induced protoporphyrin IX), products of its photodecomposition, and reduced hemoglobin, and changes in the scattering properties of the tissues with the use of sources of broadband and laser and fiber-optical probe, with subsequent automatic classification of spectroscopic characteristics used for evaluation of the efficacy of conduct resection, wherein the a source of broadband radiation in the wavelength range from 500 to 600 nm nm and a source of excitation fluorescence of laser radiation with a wavelength in the 620-640 nm, the registration of spectra of the diffuse reflection of broadband and laser radiation, as well as fluorescence are performed simultaneously.

2. The method according to claim 1, wherein the automatic processing of spectroscopic characteristics of the use automatic classification algorithm method To nearest neighbors with the definition of a weight facilities this point to each of the previously defined classes of tissue.

3. The method according to claim 1, characterized in that the results of automatic classification form a sound signal, modulated by the loudness and frequency depending on the degree of malignancy of the tissue studied.

 

© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.